Decision language models as affordable and rapid alternatives to LLM judges of clinical generative AI

arXiv:2610.28826v1 Announce Type: new Abstract: Automated judges of clinical artificial intelligence (AI) outputs are necessary, but large language model (LLM) judges are costly and slow at scale. We compared Jev, a decision language model that returns structured judgments, with frontier and open-weight LLM judges in four use cases. On 118 pediatric answers, Jev's agreement with physicians' ordinal quality ratings (Gwet's AC2 0.50; expected score 0.53) matched or exceeded that of seven of 12 LLM judges, including frontier models, Claude Opus 5.5 (0.49) and GPT-6 (0.38). On physician-graded binary HealthBench criteria, Jev matched or exceeded four of six LLM judges. On MedHELM's open-ended tasks, Jev's agreement with a three-LLM jury approached or exceeded the jurors' internal agreement. On HealthBench Professional, Jev matched the benchmark's reference judge, GPT-5.4, on 91% of criteria (other judges, 91-93%). Frontier judges cost 73-294 times more than Jev and took 7-57 times longer. Jev may enable efficient clinical AI evaluation at scale.

Jev's efficiency and accuracy may lead to widespread adoption of clinical AI evaluation, potentially replacing human judges.

The item reports a new decision language model, Jev, that matches or exceeds the performance of costly and slow large language model judges for evaluating clinical AI, potentially improving efficiency and reducing costs. However, it does not specify broader societal impacts or risks, so the overall implication is mildly positive with some uncertainty.

This is a methods and benchmarking paper about evaluation tooling, not a deployment or capability claim with direct societal impact. It could support safer scaling of clinical AI oversight but evidence of real-world effect is absent, so implications are modest either way.

The research suggests a method to make the evaluation of clinical AI more affordable and faster, which could lead to more widespread and efficient deployment of AI in healthcare. This development addresses a significant practical barrier to clinical AI adoption, thus implying a positive impact on human health and well-being. The study is a preprint, indicating it has not yet undergone peer review.

SOURCE     arXiv cs.AI (tier 1)
   ↓
DOCUMENT   337d7b70-b04b-4d1d-aea0-e655d45fbfc7
           https://arxiv.org/abs/2610.28826
   ↓
EVIDENCE   3 extracted excerpts
   ↓
MODEL RUN  4 runs, methodology 1.0.1
   ↓
SCORE      +6  (Mixed or uncertain)
   ↓
CONFIDENCE 55%